LOX and neoplasm: ECM modifying enzymes such as matrix metalloproteinases (MMPs), heparanase, cathepsins, plasminogen activator (PA) and the lysyl oxidase (LOX) family are in charge of ECM structuring and turnover and their deregulated expression in tumours, significantly contribute to cancer progression and metastasis.